Literature DB >> 11517319

The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV.

A D Sullivan1, J Wigginton, D Kirschner.   

Abstract

We explore the impact of a host genetic factor on heterosexual HIV epidemics by using a deterministic mathematical model. A protective allele unequally distributed across populations is exemplified in our models by the 32-bp deletion in the host-cell chemokine receptor CCR5, CCR5Delta32. Individuals homozygous for CCR5Delta32 are protected against HIV infection whereas those heterozygous for CCR5Delta32 have lower pre-AIDS viral loads and delayed progression to AIDS. CCR5Delta32 may limit HIV spread by decreasing the probability of both risk of infection and infectiousness. In this work, we characterize epidemic HIV within three dynamic subpopulations: CCR5/CCR5 (homozygous, wild type), CCR5/CCR5Delta32 (heterozygous), and CCR5Delta32/CCR5Delta32 (homozygous, mutant). Our results indicate that prevalence of HIV/AIDS is greater in populations lacking the CCR5Delta32 alleles (homozygous wild types only) as compared with populations that include people heterozygous or homozygous for CCR5Delta32. Also, we show that HIV can provide selective pressure for CCR5Delta32, increasing the frequency of this allele.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517319      PMCID: PMC56941          DOI: 10.1073/pnas.181325198

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

Review 1.  Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research.

Authors:  M P D'Souza; V A Harden
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440

2.  The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.

Authors:  N L Michael; G Chang; L G Louie; J R Mascola; D Dondero; D L Birx; H W Sheppard
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

3.  The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration.

Authors:  I F Hoffman; C S Jere; T E Taylor; P Munthali; J R Dyer; J J Wirima; S J Rogerson; N Kumwenda; J J Eron; S A Fiscus; H Chakraborty; T E Taha; M S Cohen; M E Molyneux
Journal:  AIDS       Date:  1999-03-11       Impact factor: 4.177

4.  Quantifying the intrinsic transmission dynamics of tuberculosis.

Authors:  T C Porco; S M Blower
Journal:  Theor Popul Biol       Date:  1998-10       Impact factor: 1.570

5.  A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.

Authors:  L G Kostrikis; Y Huang; J P Moore; S M Wolinsky; L Zhang; Y Guo; L Deutsch; J Phair; A U Neumann; D D Ho
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

6.  Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32.

Authors:  N L Michael; J A Nelson; V N KewalRamani; G Chang; S J O'Brien; J R Mascola; B Volsky; M Louder; G C White; D R Littman; R Swanstrom; T R O'Brien
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).

Authors:  D H McDermott; P A Zimmerman; F Guignard; C A Kleeberger; S F Leitman; P M Murphy
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

9.  Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV.

Authors:  B Leynaert; A M Downs; I de Vincenzi
Journal:  Am J Epidemiol       Date:  1998-07-01       Impact factor: 4.897

10.  Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.

Authors:  R I Connor; K E Sheridan; D Ceradini; S Choe; N R Landau
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

View more
  12 in total

1.  Interrogating a high-density SNP map for signatures of natural selection.

Authors:  Joshua M Akey; Ge Zhang; Kun Zhang; Li Jin; Mark D Shriver
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

2.  CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women.

Authors:  Sean Philpott; Barbara Weiser; Patrick Tarwater; Sten H Vermund; Cynthia A Kleeberger; Stephen J Gange; Kathryn Anastos; Mardge Cohen; Ruth M Greenblatt; Andrea Kovacs; Howard Minkoff; Mary A Young; Paolo Miotti; Michelle Dupuis; Chih-Hsiung Chen; Harold Burger
Journal:  J Infect Dis       Date:  2003-01-29       Impact factor: 5.226

3.  Impact of ERCC2 gene polymorphism on HIV-1 disease progression to AIDS among North Indian HIV patients.

Authors:  Ranbir Chander Sobti; Nega Berhane; Salih Abdul Mahdi; Rupinder Kler; Seyed Ali Hosseini; Vijish Kuttiat; Ajay Wanchu
Journal:  Mol Biol Rep       Date:  2010-02-02       Impact factor: 2.316

4.  Genetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patients.

Authors:  S Mascheretti; H Hinrichsen; S Ross; P Buggisch; J Hampe; U R Foelsch; S Schreiber
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

5.  Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia Virus.

Authors:  Raymond S Weinstein; Michael M Weinstein; Kenneth Alibek; Michael I Bukrinsky; Beda Brichacek
Journal:  BMC Immunol       Date:  2010-05-18       Impact factor: 3.615

6.  Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.

Authors:  Weijing He; Stuart Neil; Hemant Kulkarni; Edward Wright; Brian K Agan; Vincent C Marconi; Matthew J Dolan; Robin A Weiss; Sunil K Ahuja
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

Review 7.  Mathematical and computational approaches can complement experimental studies of host-pathogen interactions.

Authors:  Denise E Kirschner; Jennifer J Linderman
Journal:  Cell Microbiol       Date:  2009-04       Impact factor: 3.715

8.  Cord blood stem cell therapy for acquired immune deficiency syndrome.

Authors:  Gabriel Gonzalez; Elizabeth J Shpall; Joseph C Gathe; Richard R Behringer
Journal:  Stem Cells Dev       Date:  2009 Jan-Feb       Impact factor: 3.272

9.  Distribution of the CCR5delta32 allele (gene variant CCR5) in Rondônia, Western Amazonian region, Brazil.

Authors:  Josileide Duarte de Farias; Marlene Guimarães Santos; Andonai Krauze de França; Daniel Delani; Mauro Shugiro Tada; Almeida Andrade Casseb; Aguinaldo Luiz Simões; Vera Engracia
Journal:  Genet Mol Biol       Date:  2012-01-06       Impact factor: 1.771

10.  Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy.

Authors:  Hemant Kulkarni; Vincent C Marconi; Brian K Agan; Carole McArthur; George Crawford; Robert A Clark; Matthew J Dolan; Sunil K Ahuja
Journal:  PLoS One       Date:  2008-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.